LivaNova PLC Share Price & Technical Analysis
LIVN · $75.27 (+1.95%)
Healthcare / Medical Devices
$75.27
+1.95%
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. The company operates in two segments, Cardiopulmonary and Neuromodulation. T…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
22% return in May, 4% avg return in past 3 year May month.
22% return in 2026, 12% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 7% | 8% | -8% | -6% | 22% | – | – | – | – | – | – | – | 22% |
| 25 | 7% | -15% | -7% | -6% | 17% | 4% | -5% | 35% | -6% | 3% | 21% | -3% | 44% |
| 24 | -5% | 12% | 2% | 0% | 2% | -10% | -10% | 1% | 5% | -2% | 3% | -12% | -14% |
| 23 | 0% | -16% | -8% | 10% | -7% | 16% | 14% | -5% | -5% | -7% | -5% | 16% | 4% |
| 22 | -14% | 4% | 4% | -7% | -11% | -8% | 3% | -11% | -9% | -7% | 15% | -1% | -42% |
Monthly return % by calendar month · historical pattern, not a forecast
Bullish · Strong · Strong
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and difficult-to-treat depression. This segment also includes the development and clinical testing of LivaNova's aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, and other healthcare professionals, hospitals, and other medical institutions and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$3.88B
P/E ratio
36.08
52W high
$75.39
52W low
$41.02
Volume
1,67,430
Beta
0.82
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is LivaNova PLC share price today?
- LivaNova PLC (LIVN) last traded around $75.27 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does LIVN have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for LIVN. Download the app for real-time alerts.
- How can I analyze LivaNova PLC stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.